Skip to main content

Table 1 Sex, tumor stage, and age of the samples from the ICGC database

From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

  Number Ratio
Gender
Female 68 0.261538462
Male 192 0.738461538
Stage
Stage1 40 0.153846154
Stage2 117 0.45
Stage3 80 0.307692308
Stage4 23 0.088461538
Age
> 60 205 0.788461538
< 60 55 0.211538462